Advertisement
Screener

MARKER THERAPEUTICS, INC. (MRKR) Gain (Loss) on Disposition of Assets for Financial Service Operations

MARKER THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets for Financial Service Operations

MARKER THERAPEUTICS, INC. (MRKR) reported Gain (Loss) on Disposition of Assets for Financial Service Operations of $5.40 thousand for the 179-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.

Discontinued › Expense Statement › Operating Expenses

us-gaap:GainsLossesOnSalesOfAssets · last filed 2014-08-18

  • MARKER THERAPEUTICS, INC. gain (loss) on disposition of assets for financial service operations for the quarter ending 2012-06-30 was $0.00.
  • MARKER THERAPEUTICS, INC. gain (loss) on disposition of assets for financial service operations for the quarter ending 2011-06-30 was $0.00.
Period endGain (Loss) on Disposition of Assets for Financial Service Operations 3 monthGain (Loss) on Disposition of Assets for Financial Service Operations 6 monthGain (Loss) on Disposition of Assets for Financial Service Operations 143 monthGain (Loss) on Disposition of Assets for Financial Service Operations 146 monthGain (Loss) on Disposition of Assets for Financial Service Operations 149 monthGain (Loss) on Disposition of Assets for Financial Service Operations 152 monthGain (Loss) on Disposition of Assets for Financial Service Operations 155 monthGain (Loss) on Disposition of Assets for Financial Service Operations 158 monthGain (Loss) on Disposition of Assets for Financial Service Operations 161 monthGain (Loss) on Disposition of Assets for Financial Service Operations 164 monthGain (Loss) on Disposition of Assets for Financial Service Operations 167 monthGain (Loss) on Disposition of Assets for Financial Service Operations 170 monthGain (Loss) on Disposition of Assets for Financial Service Operations 173 monthGain (Loss) on Disposition of Assets for Financial Service Operations 179 month
2014-06-30$5.40K
10-Q · filed 2014-08-18
2013-12-31-$5.40K
10-Q/A · filed 2014-05-21
2013-09-30-$5.40K
10-Q · filed 2013-11-19
2013-06-30-$5.40K
10-Q · filed 2013-08-19
2013-03-31-$5.40K
10-Q/A · filed 2013-08-19
2012-12-31-$5.40K
10-K · filed 2013-05-15
2012-09-30-$5.40K
10-Q · filed 2012-11-19
2012-06-30$0.00
10-Q/A · filed 2012-09-12
$0.00
10-Q/A · filed 2012-09-12
-$5.40K
10-Q/A · filed 2012-09-12
2012-03-31-$5.40K
10-Q · filed 2012-05-21
2011-12-31-$5.40K
10-K · filed 2012-04-16
2011-09-30-$5.40K
10-Q · filed 2011-11-21
2011-06-30$0.00
10-Q/A · filed 2012-09-12
$0.00
10-Q/A · filed 2012-09-12
-$5.40K
10-Q · filed 2011-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Rocket One Inc. (RKTO)United States$0.019B
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66